Famciclovir is an antiviral medication available as a generic pill in strengths of 250 mg and 500 mg. It belongs to the antiviral class and is marketed worldwide under its chemical name rather than a brand name. In Hong Kong, Famciclovir is a prescription-only product regulated by the Department of Health. The medication is supplied as oral tablets designed for systemic absorption.
Famciclovir is a prodrug that is rapidly converted after ingestion to its active form, penciclovir. Penciclovir mimics the natural nucleoside guanosine and becomes incorporated into viral DNA by the viral DNA polymerase enzyme. This incorporation halts the elongation of the viral genome, preventing the virus from replicating. Because the activation of penciclovir relies on a viral enzyme (thymidine kinase), the drug preferentially affects infected cells while sparing healthy cells. Clinical onset of antiviral activity typically occurs within a few hours, with peak concentrations reached after 2-3 hours for the 500 mg tablet. The drug’s half-life supports once- or twice-daily dosing schedules for most indications.
Famciclovir is approved in Hong Kong for the following indications, consistent with approvals from major regulatory agencies such as the FDA and EMA:
These uses target adult patients; pediatric dosing follows separate guidelines and is not covered in this adult-focused article.
Ideal candidates are adults with confirmed infections caused by herpes simplex virus (HSV-1, HSV-2) or varicella-zoster virus (VZV) who require systemic antiviral therapy.
Absolute contraindications
Relative contraindications
Special populations
When comprehensive interaction data are unavailable, patients should inform their prescriber of all prescription drugs, over-the-counter products, supplements, and herbal remedies they are using.
Routine monitoring for most adults on famciclovir consists of clinical assessment for symptom resolution and any adverse effects. In patients with known kidney disease, serum creatinine should be measured before initiating therapy and periodically during treatment. Pregnant or breastfeeding patients require close obstetric follow-up.
This article provides educational information about famciclovir and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Famciclovir is primarily eliminated by the kidneys, so liver disease generally does not require dose adjustment. However, patients with severe hepatic impairment should discuss any concerns with their clinician, as co-existing conditions may affect overall medication safety.
Most adults notice a reduction in pain and faster crusting of lesions within 48-72 hours of initiating therapy, although complete resolution may take several weeks depending on age and severity.
Famciclovir can be used for episodic treatment of HSV-1 labial lesions when taken at the first sign of a prodrome. It is not approved for continuous prophylaxis of cold sores, and other agents such as aciclovir are more commonly recommended for that purpose.
Take the missed dose as soon as you remember, unless the next dose is due within a few hours. In that case, skip the missed dose and continue with the regular schedule-do not double the dose.
When traveling, keep the medication in its original container, carry a copy of the prescription, and store it at room temperature away from humidity. If you are flying, inform security that you have a prescription medication in pill form.
There is no known pharmacokinetic interaction between famciclovir and combined oral contraceptives. Routine contraceptive use remains effective while on antiviral therapy.
The two strengths allow clinicians to tailor dosing based on the specific indication and the patient’s renal function, offering flexibility for short-term high-dose regimens and lower-dose maintenance therapy.
Famciclovir does not affect uric acid metabolism, so it is generally safe for patients with gout. Still, if you are taking medications such as probenecid for gout, discuss potential interactions with your healthcare provider.
Both are guanosine analogues, but famciclovir (via penciclovir) has a longer intracellular half-life, allowing less frequent dosing compared with aciclovir, which often requires three to five daily doses.
Flushing antiviral tablets can introduce active pharmaceutical ingredients into water supplies, potentially affecting microbial ecosystems. Follow local take-back programs or the Department of Health’s disposal guidelines to minimize environmental harm.
